ONCOTHERAPY SCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16 JPY | 0.00% |
|
-5.88% | -30.43% |
| 29/04 | Poland's Tusk calls prosecutor over potential Orlen scandal | RE |
| 22/04 | OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024 | CI |
Chart calendar OncoTherapy Science, Inc.
7220c87c757219a6b4f2454c.NzX1mCILJ3VIMlz_pPM419PYJhSo9vEeraIsTZQHcRc.VXKg0nc8SDYJVRKM9Z9atZqfdVH8hr4q--NBN_VrFnQETZiuQU1qOy55aA~80db50cd227ab23f5554fd3460aa84e3
Past events on OncoTherapy Science, Inc.
| 05/08/2022 | Q1 2023 Earnings Release |
| 06/05/2022 | FY 2022 Earnings Release |
| 04/02/2022 | Q3 2022 Earnings Release |
| 06/08/2021 | Q1 2022 Earnings Release |
| 22/06/2021 | Shareholders Meeting |
| 07/05/2021 | FY 2021 Earnings Release |
| 06/11/2020 | Interim 2020 Earnings Release |
| 07/08/2020 | Q1 2021 Earnings Release |
| 10/05/2019 | FY 2018 Earnings Release (Projected) |
| 01/02/2019 | Q3 2018 Earnings Release (Projected) |
| 10/08/2018 | Q1 2018 Earnings Release |
| 02/02/2018 | Q3 2017 Earnings Release |
| 03/11/2017 | Interim 2017 Earnings Release (Projected) |
| 04/08/2017 | Q1 2017 Earnings Release |
| 19/05/2017 | FY 2016 Earnings Release (Projected) |
| 03/02/2017 | Q3 2016 Earnings Release |
| 04/11/2016 | Interim 2016 Earnings Release |
| 29/07/2016 | Q1 2016 Earnings Release (Projected) |
| 29/01/2016 | FY 2015 Earnings Release (Projected) |
| 29/01/2016 | FY 2015 Earnings Release (Projected) |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 280 | 316 | 332 | 1 153 | 1 134 | 610 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million JPY | Released Forecast Spread | -2 953 | -2 189 | -1 637 | -2 052 | -1 106 | -1 120 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -3 194 | -2 236 | -1 560 | -2 570 | -1 116 | -1 285 |
|
Net income Million JPY | Released Forecast Spread | -2 934 | -2 238 | -1 561 | -2 571 | -1 118 | -1 288 |
|
EPS JPY | Released Forecast Spread | -19,9 | -13,7 | -8,86 | -13,7 | -5,81 | -6,05 |
| Announcement Date | 10/05/19 | 08/05/20 | 07/05/21 | 06/05/22 | 12/05/23 | 10/05/24 |
Quarterly results
| Fiscal Period | March | 2020 S1 | 2021 S1 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 | 2024 Q1 | 2024 S1 | 2024 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million JPY | Released Forecast Spread | 104 | 100 | 240 | 95,0 | 385 | 514 | 185 | 148 | 356 | 110 |
|
EBIT Million JPY | Released Forecast Spread | -1 218 | -838 | -948 | -762 | -307 | -618 | -286 | -386 | -694 | -278 |
|
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -1 256 | -755 | -1 228 | -909 | -277 | -612 | -299 | -399 | -709 | -276 |
|
Net income Million JPY | Released Forecast Spread | -1 256 | -756 | -1 229 | -910 | -277 | -613 | -300 | -400 | -710 | -277 |
|
EPS JPY | Released Forecast Spread | -8,01 | -4,29 | -6,74 | -4,78 | -1,44 | -3,19 | -1,55 | -1,99 | -3,42 | -1,26 |
| Announcement Date | 08/11/19 | 06/11/20 | 05/11/21 | 04/02/22 | 05/08/22 | 04/11/22 | 10/02/23 | 10/08/23 | 10/11/23 | 09/02/24 |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
| 30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for OncoTherapy Science, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4564 Stock
- Calendar OncoTherapy Science, Inc.